Kanak Fairdeal (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.54%
- Profit Growth -26.49%
- Ebitda 277.00%
- Net Worth 12.68%
- Total Assets 151.42%
About Kanak Fairdeal (India)
Kanak Fairdeal (India) Private Limited (KFIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 March 2007 and has a history of 17 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Chetan Medicaments Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Gupta and Rajkumar Kochle serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2007PTC168375
-
Company No.
168375
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Mar 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kanak Fairdeal (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Gupta
|
Director | 01-Oct-2016 | Current |
|
Rajkumar Kochle
|
Director | 14-Feb-2023 | Current |
Financial Performance of Kanak Fairdeal (India).
Kanak Fairdeal (India) Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 100.54% increase. The company also saw a substantial fall in profitability, with a 26.49% decrease in profit. The company's net worth Soared by an impressive increase of 12.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanak Fairdeal (India)?
In 2019, Kanak Fairdeal (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shreenath Agrico Private LimitedAmit Gupta is a mutual person
-
Parenteral Commercial Services Private Limited
Amit Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kanak Fairdeal (India)?
Unlock and access historical data on people associated with Kanak Fairdeal (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanak Fairdeal (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanak Fairdeal (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
